NYSE:CPHI China Pharma (CPHI) Stock Price, News & Analysis $0.66 +0.00 (+0.61%) Closing price 10/2/2026 04:00 PM EasternExtended Trading$0.66 +0.00 (+0.30%) As of 10/2/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsFinancialsNews and TrendsOwnershipSEC Filings About China Pharma Stock (NYSE:CPHI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get China Pharma alerts:Sign Up Key Stats Today's Range$0.64▼$0.6650-Day Range$0.65▼$1.3052-Week Range$0.38▼$19.19Volume118,902 shsAverage Volume1.63 million shsMarket Capitalization$28.27 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview China Pharma Holdings, Inc. is a pharmaceutical company based in Harbin, Heilongjiang Province, China. Through its operating subsidiaries, the company develops, manufactures and markets pharmaceutical products and nutritional supplements primarily for the Chinese market. Its product portfolio has included prescription and over-the-counter medicines in dosage forms such as injections, tablets, capsules, granules and oral solutions. The company has also offered products used in areas including antibiotics, cardiovascular care, respiratory treatment, neurology and general health maintenance. Product availability and focus may vary over time as China Pharma updates its offerings and regulatory approvals. China Pharma serves hospitals, pharmaceutical distributors and retail channels in China. Publicly available company information provides limited detail about its current executive leadership and international operations, so the company is best characterized as a China-focused pharmaceutical manufacturer and marketer.AI Generated. May Contain Errors. Read More Receive CPHI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for China Pharma and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CPHI Stock News HeadlinesChina Pharma (NYSE:CPHI) Stock Jumps 1% - Time to Buy?October 1 at 2:03 AM | americanbankingnews.comChina Pharma Holdings IncSeptember 4, 2026 | markets.ft.comReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.October 3 at 1:00 AM | Base Camp Trading (Ad)China Pharma Holdings, Inc.: China Pharma Announces Pricing of $5 Million Registered Direct OfferingJuly 24, 2026 | finanznachrichten.deChina Pharma Holdings, Inc. Announces Closing of $5.0 Million Registered Direct OfferingJuly 23, 2026 | prnewswire.comChina Pharma Holdings Announces New Capital Raising AgreementJuly 22, 2026 | tipranks.comChina Pharma Announces Pricing of $5 Million Registered Direct OfferingJuly 22, 2026 | prnewswire.comChina Pharma Holdings, Inc. Comments on Unusual Market ActivityJuly 21, 2026 | prnewswire.comSee More Headlines CPHI Stock Analysis - Frequently Asked Questions How have CPHI shares performed this year? China Pharma's stock was trading at $1.21 on January 1st, 2026. Since then, CPHI shares have decreased by 45.7% and is now trading at $0.6570. How were China Pharma's earnings last quarter? China Pharma Holdings, Inc. (NYSE:CPHI) released its earnings results on Wednesday, August, 15th. The company reported ($100.00) earnings per share for the quarter. The company earned $3.17 million during the quarter. China Pharma had a negative trailing twelve-month return on equity of 63.93% and a negative net margin of 85.56%. When did China Pharma's stock split? China Pharma's stock reverse split on the morning of Tuesday, April 15th 2025.The 1-10 reverse split was announced on Friday, April 4th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Monday, April 14th 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of China Pharma? Shares of CPHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of China Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that China Pharma investors own include Micron Technology (MU), Inovio Pharmaceuticals (INO), Tonix Pharmaceuticals (TNXP) and Bionano Genomics (BNGO). Company Calendar Last Earnings8/15/2018Today10/03/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 CPHI's financial health is in the Red zone, according to TradeSmith. CPHI has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNYSE:CPHI CIK1106644 Webwww.chinapharmaholdings.com Phone8689866811730Fax86-898-6681-9024Employees221Year Founded1999Profitability EPS (Trailing Twelve Months)($0.43) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.08 million Net Margins-85.56% Pretax Margin-85.56% Return on Equity-63.93% Return on Assets-31.42% Debt Debt-to-Equity Ratio0.22 Current Ratio0.79 Quick Ratio0.26 Sales & Book Value Annual Sales$3.91 million Price / Sales7.22 Cash FlowN/A Price / Cash FlowN/A Book Value$0.70 per share Price / Book0.94Miscellaneous Outstanding Shares43,022,000Free Float15,918,000Market Cap$28.27 million OptionableNot Optionable Beta1.04 Social Links 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NYSE:CPHI) was last updated on 10/3/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China Pharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China Pharma With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
